Overview

Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica

Status:
Unknown status
Trial end date:
2019-12-01
Target enrollment:
Participant gender:
Summary
Clinical, psychophysical, behavioral or genetic factor will predict the response to opioid treatment in patients with chronic neuropathic pain.
Phase:
Phase 2
Details
Lead Sponsor:
Rambam Health Care Campus
Treatments:
Levomilnacipran
Milnacipran
Morphine
Norepinephrine